Recombinant KLK1: the next step in stroke and preeclampsia treatment
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to restore blood flow, improve endothelial…
No news content available.
Join this webinar to learn how WRPRFa, a novel peptide tool selective for ASIC3, advances pain research and supports drug discovery in peripheral noci...
Explore how a Weight of Evidence (WoE) approach uses in vitro methods and artificial intelligence (AI) to transform carcinogenicity risk assessment, r...
Join this expert-led webinar to learn how to break through common bottlenecks in TCR discovery with practical strategies that help teams move faster a...
Our latest 'Beyond the Lab' report explores cutting-edge advancements in stem cell research, highlighting their potential to revolutionise treatments for chronic diseases and cance...
Our latest 'Beyond the Lab' report explores cutting-edge advancements in stem cell research, highlighting their potential to revolutionise treatments for chronic diseases and cance...
Our latest 'Beyond the Lab' report explores cutting-edge advancements in stem cell research, highlighting their potential to revolutionise treatments for chronic diseases and cance...
A new Drug Target Review issue is now ready to download! This issue features articles on CRISPR, personalised medicine and screening. ...
Amidst a new wave of innovation in antibody research, this report highlights recent breakthroughs across fields such as cancer research and neuroscience, showcasing how advancement...
Unlock Exclusive Industry Insights